We are anchored in our founder’s conviction that access to healthcare should not be defined by affluence. We are driving innovation globally that delivers high-quality, affordable medicines for all.
CONTACT
Group Companies
Our purpose
Our model: Lab to patient
We aim to achieve health equity.
With global scale and fully integrated, in-house capabilities spanning R&D to commercial supply chains, we are uniquely equipped to consistently and reliably deliver medicines to patients worldwide.
Our global impact
Patients are at the center of everything we do, we are doubling down on our global commitment to address diabetes, cancer and other debilitating diseases.
Innovative
We harness the power of the latest technologies to advance affordable innovation – while upholding the highest quality standards.
Know more >>
Corporate Overview
Download Our Integrated
Annual Report 2025
Accelerating Reach.
Expanding Access. Propelling Growth.
Our Businesses
GENERICS
BIOSIMILARS
RESEARCH SERVICES
NOVEL BIOLOGICS
Factsheet
Biocon at a glance
Advancing
biotechnology for
biotechnology for
45+
years
Improving lives
across
across
120+
countries
Talented, dedicated
workforce of
workforce of
16,500+
employees
A culture of innovation
Biocon at a glance
326
Patents Granted
(Generics)
Till end of FY25
(Generics)
Till end of FY25
400
Patents Granted
(Biosimilars)
Till end of FY 25
(Biosimilars)
Till end of FY 25
215+
cGMP Approvals
across Generics &
Biosimilars
across Generics &
Biosimilars
12
Biologics were taken
from 'Lab to Market':
2 Novels and
10 Biosimilars
from 'Lab to Market':
2 Novels and
10 Biosimilars
vision
Guided by our shared purpose to improve global health, and the courage to lead with conviction, we are pursuing our bold ambition to deliver affordable, lifesaving medicines to patients around the world.
values
Integrity and ethical behaviour
Performance-driven work culture
Value creation through innovation and differentiation
Quality through compliance and best practices
Collaboration, teamwork and mutual respect
mission
Making lifesaving medicines affordable and accessible to patients everywhere.
Know more
about us
CORPORATE GOVERNANCE
KEY THERAPEUTIC AREAS
RESEARCH SERVICES
OUR CULTURE
